Morning news

25/05/2025  8.00AM
Good morning 
News Headline from Leading Financial News Papers,  Compiled by *Rudra Shares* 
Sunday, 25 May 2025


• Upcoming IPOs: 4 mainboard, 5 SME IPOs to hit D-Street next week

• 'Q4 Results, F&O expiry, GDP data, global cues to guide markets this week

• Next week may test traders' patience; Nifty needs to break 25,150 for the next leg up

• Aegis Vopak Terminals IPO: Institutional investors buy Rs 1,260 crore via anchor book

• Leela Hotels IPO opens on May 26: Schloss Bangalore mobilises Rs 1,575 crore via anchor book

• Astonea Labs, Nikita Papers IPOs to open for subscription on May 27

• Gold set to gain further on trade jitters and US fiscal concerns; oil and metals face selling pressure

• Magnet winding wires maker KSH International plans Rs 745-crore IPO, files draft papers with SEBI

• NR Vandana Tex Industries to be fifth SME IPO opening next week

• NTPC eyes robust 3-year capex growth, bets big on nuclear expansion

• Apple’s US manufacturing push could backfire; India still most viable option outside China

• RBI makes it easier to claim dormant funds

• 'Demerger to bring strategic clarity, long-term returns for shareholders: Tata Motors chairman N Chandrasekaran

• Stainless steel players to take up import issue at global summit in Mumbai next month

• Maharashtra rolls out new EV policy; targets 30 pc adoption by 2030

• India's Q4 FY25 GDP growth likely to accelerate to 7.0%: UBI report

• Finance Ministry urges banks, DRTs to speed up debt recovery

• NITI Aayog to redefine urban boundaries using economic data to boost growth and infrastructure

• FTSE Rejig: Hyundai, Swiggy to join largecap segment

•: Eternal may see $840 mn worth outflow on weight cuts

•  FinMin makes push for faster debt recovery

• NITI Aayog to redefine urban boundaries

• FIIs sell Rs 11,591 cr in Indian stocks this week

• China’s India headache: The growing pharmaceutical industry


For more details:
Attention Investor :
Dos and Don’ts for Retail Investors:   1) Offering fixed/guaranteed/regular returns/ capital protection schemes in stock markets whether written or oral is not allowed. Any of our representative or Authorised Person (AP) cannot offer fixed/guaranteed/regular returns/capital protection schemes.    2) Any of our representative or Authorised Person (AP) cannot enter into any loan agreement to pay interest on the funds/securities offered by you.    3) Do not fall prey to emails, SMSs and online videos luring you to trade in stock/ securities / schemes promising high returns/profits.    4) Trading in derivatives involves high risk and accordingly investors should understand the product well before trading in such segments/products.    5) Dealing in cash is prohibited. Do not place any fund and / or securities with any of our representative or Authorised Person (AP) under any circumstances.    6) Do not share your login ID, password, OTP, TPIN with any person including any of our employee/representative or Authorised Person (AP) under any circumstances. 7) Ensure to fill all the required details in the 'KYC' document by yourself and receive copy of your 'KYC' documents.    8) Ensure that all your trades are executed as per your instructions.    9) Always keep your mobile number and email id updated with us. Don't ignore any SMSs / e-mails with regards to contract notes/trades/funds and securities balances sent by RUDRA/Exchange. Verify the details of the same and report discrepancy, if any, to RUDRA in writing immediately.    10) Please verify Bank Account details from our website before transferring funds to us.

SEBI REGN. (STOCK BROKER) - NSE-CM/FO/CD / BSE-CM/FO/CD / MCX / NCDEX - INZ000004937 | SEBI REGN. (DP) IN-DP-558-2021

Attention Investors

  1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.
  2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  3. Pay 20% upfront margin of the transaction value to trade in cash market segment.
  4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

(Issued in the interest of Investors.)

Risk Disclosure on Derivatives

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

Important Message

This is to inform that, many instances were reported by general public where fraudsters are cheating general public by misusing our brand name RUDRA SHARES. The fraudsters are luring the general public to transfer them money by falsely committing attractive brokerage / investment schemes of share market and/or Mutual Funds and/or personal loan facilities. Though as for as possible, we initiate legal actions against the fraudsters, we request you to not fall prey to such fraudsters. You can check about our products and services by visiting our website www.rudrashares.com. You can also write to us at compliance@rudrashares.com, to know more about products and services.

Copyright © 2024 RUDRA SHARES & STOCK BROKERS LTD. All rights Reserved.

Designed & Developed by CMOTS Infotech (ISO 9001:2015 certified)